Universal Health Services Inc. Reports 9.6% Increase in Net Revenues and 22.1% Rise in Net Income for Q2 2025; EPS Grows to $5.43

Reuters
07/29
<a href="https://laohu8.com/S/UHS">Universal Health</a> Services Inc. Reports 9.6% Increase in Net Revenues and 22.1% Rise in Net Income for <a href="https://laohu8.com/S/QTWO">Q2</a> 2025; EPS Grows to $5.43

Universal Health Services Inc. (UHS) has announced its financial results for the second quarter and first six months of 2025. The company reported a net income attributable to UHS of $353.2 million, or $5.43 per diluted share, during the second quarter of 2025, an increase from $289.2 million, or $4.26 per diluted share, during the same period in 2024. Net revenues for the second quarter increased by 9.6% to $4.284 billion, compared to the second quarter of 2024. For the first six months of 2025, UHS reported a net income of $669.9 million, or $10.23 per diluted share, up from $551.0 million, or $8.08 per diluted share, during the same period in 2024. Net revenues for the first half of 2025 increased by 8.2% to $8.384 billion from $7.751 billion in the comparable period of the previous year. In terms of outlook, UHS has revised its full-year 2025 operating results forecast. The company now estimates its Adjusted EBITDA, net of NCI, to be approximately $2.458 billion to $2.543 billion, reflecting increases of 4.3% to 2.4% over the original 2025 forecast. Additionally, the revised forecast for Adjusted EPS-diluted is estimated to be between $20.00 and $21.00 per share, representing increases of 8.4% to 5.3% over the original forecast.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Universal Health Services Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: PH39008) on July 28, 2025, and is solely responsible for the information contained therein.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10